Carpal Tunnel Syndrome Treated With 830nm Diode Laser - Full Text View

Carpal Tunnel Syndrome Treated With 830nm Diode Laser (CTS)

This study is currently recruiting participants.

Verified by Chung Shan Medical University, August 2007

Sponsors and Collaborators:	Chung Shan Medical University National Taiwan University
Information provided by:	Chung Shan Medical University
ClinicalTrials.gov Identifier:	NCT00514462

Purpose

The purpose of this study is to determine that 830nm diode laser directly above the transverse carpal ligament (between the pisiform and navicular bone) on subjects' wrists, and test this therapeutic effect.

Condition	Intervention	Phase
Carpal Tunnel Syndrome	Device: diode laser	Phase I Phase II

Genetics Home Reference related topics: Charcot-Marie-Tooth disease hereditary neuropathy with liability to pressure palsies

MedlinePlus related topics: Carpal Tunnel Syndrome

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Single Blind (Subject), Placebo Control, Single Group Assignment, Efficacy Study
Official Title:	Instiutional Review Board of Chung Shan Medical University Hospital

Further study details as provided by Chung Shan Medical University:

Primary Outcome Measures:

treatment effect [ Time Frame: two weeks ]

Secondary Outcome Measures:

EMG, Jamar dynamometer, Carpal tunnel function disability form [ Time Frame: two weeks ]

Estimated Enrollment:	30
Study Start Date:	July 2007
Estimated Study Completion Date:	August 2007

Arms	Assigned Interventions
A: Experimental low level laser instrument (Painless Light PL-830, Advanced Chips & Products Crop., USA)	Device: diode laser wavelength at 830nm, 9.7J/cm2 for 10 min

Detailed Description:

The low level laser instrument (Painless Light PL-830, Advanced Chips & Products Crop., USA) emitted two light beams with a distance of 2.5cm between them by two laser diodes.

Eligibility

Ages Eligible for Study:	18 Years to 70 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

no operation of the wrist
first onset of CTS more than 1 year ago with repeated episodes
never having laser treatment before.

Exclusion Criteria:

patients with any rheumatoid arthritis
history of metabolic disease or paralyzed limbs caused by stroke
taking any anti-inflammatory drug
with other treatments, such as acupuncture, physical therapy and wearing orthosis

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00514462

Contacts

Contact: Yu-Chun Yeh, Ph.D

886922002769

mandy-steven@yahoo.com.tw

Locations

China, Taiwan
Chung Shan Medical University Hospital	Recruiting
Chinese Taipei, Taiwan, China, 360
Contact: Joe-Air Jiang, Ph.D 886-2-33665341 jajiang@ntu.edu.tw

Sponsors and Collaborators

Chung Shan Medical University

National Taiwan University

Investigators

Study Director:

Chin-Ping Han, MD/PhD

Chung Shan Medical University Hospital

More Information

Study ID Numbers:	CS07040
Study First Received:	August 8, 2007
Last Updated:	August 9, 2007
ClinicalTrials.gov Identifier:	NCT00514462
Health Authority:	Taiwan: Department of Health

Study placed in the following topic categories:

Carpal Tunnel Syndrome
Roussy Levy hereditary areflexic dystasia
Charcot-Marie-Tooth Disease
Wounds and Injuries
Disorders of Environmental Origin
Mononeuropathies
Nerve Compression Syndromes

Tomaculous neuropathy
Neuromuscular Diseases
Peripheral Nervous System Diseases
Hereditary Motor and Sensory Neuropathies
Charcot Marie Tooth disease
Cumulative Trauma Disorders
Sprains and Strains

Additional relevant MeSH terms:

Median Neuropathy
Pathologic Processes
Disease
Syndrome
Nervous System Diseases

ClinicalTrials.gov processed this record on January 16, 2009